5 Best Penny Stocks to Buy Now
Asthika Goonewardene at Truist gave Compugen Ltd. (NASDAQ:CGEN) stock a target price of $4 and maintained a Buy rating on the stock in a research note issued on August 23.
Clovis Oncology Inc. (CLVS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.97 | 20,000 | Director | 20,000 | 2019-08-20 | Filing | |
| $5.70 | 20,000 | Director | 33,439 | 2019-08-16 | Filing | |
| $5.60 | 5,827 | Officer, Director | 968,787 | 2019-08-16 | Filing | |
| $5.60 | 5,100 | Officer, Director | 962,960 | 2019-08-16 | Filing | |
| $5.59 | 11,053 | Officer, Director | 957,860 | 2019-08-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 2,135 | Officer | 98,330 | 2022-11-02 | Filing | |
| $0.98 | 2,595 | Officer | 95,840 | 2022-11-02 | Filing | |
| $0.98 | 2,006 | Officer | 293,612 | 2022-11-02 | Filing | |
| $0.98 | 1,675 | Officer | 290,993 | 2022-11-02 | Filing | |
| $0.98 | 63 | Officer | 3,801 | 2022-11-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 20,000 | $2,176 | 0% | |
| 2. | 16,795 | $518 | 0.08% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
15 Best Penny Stocks To Invest In
The US equity market has been volatile since the start of 2022. The Dow 30 Index extended an eight-week consecutive losing streak.
These 5 Stocks Are Skyrocketing Today
In this article, we take a look at five stocks that are skyrocketing today.
Is CLVS A Good Stock To Buy Now?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Hedge Funds Are Dipping Their Toes Back Into Clovis Oncology Inc (CLVS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Never Been Less Bullish On Clovis Oncology Inc (CLVS)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Did Hedge Funds Drop The Ball On Clovis Oncology Inc (CLVS) ?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Were Hedge Funds Right About Dumping Clovis Oncology Inc (CLVS)?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the second ...
Hedge Fund and Insider Trading News: Ray Dalio, Tom Steyer, Bodenholm Capital, Balyasny Asset Management, AQR Capital, Magellan Midstream Partners, L.P. (MMP), Tucows Inc (TCX), and More
Hedge fund billionaire Ray Dalio knows plenty about success: He founded Bridgewater Associates, the world’s largest hedge fund with roughly $160 billion in assets.
Hedge Fund and Insider Trading News: Tom Steyer, David Shaw, Ray Dalio, Keshik Capital, Facebook Inc. (FB), Cullen/Frost Bankers, Inc. (CFR), and More
Apparently running for president is not a valid excuse for getting out of jury duty.
Billionaire Hedge Funds
